News
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
Long Island patients lost vision after taking weight loss drugs Ozempic and Wegovy, lawsuits contend
The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...
Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.
Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...
The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...
For every man who has cut carbs from his diet and dropped 10 pounds, there’s a woman who’s done exactly the same thing ...
GLP-1 drugs like Wegovy and Ozempic are designed to treat type 2 diabetes, but are widely known for their effect on weight ...
Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...
Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.
In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results